For research use only. Not for therapeutic Use.
Isatuximab（Cat No.:I044209）is a humanized IgG1 monoclonal antibody that targets CD38, a surface glycoprotein highly expressed on multiple myeloma cells. By binding to CD38, isatuximab induces cancer cell death through multiple mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct apoptosis. It also modulates the immune microenvironment by reducing immunosuppressive cells. Approved for use in combination therapies for relapsed or refractory multiple myeloma, isatuximab offers a potent, targeted treatment option that enhances response rates and prolongs progression-free survival in patients with advanced disease.
| CAS Number | 1461640-62-9 |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
